Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug;56(2):224-229.
doi: 10.1002/mus.25482. Epub 2017 Feb 13.

Physical function and mobility in children with congenital myotonic dystrophy

Affiliations

Physical function and mobility in children with congenital myotonic dystrophy

Evan M Pucillo et al. Muscle Nerve. 2017 Aug.

Abstract

Introduction: Congenital myotonic dystrophy (CDM) occurs when symptoms of myotonic dystrophy present at birth. In this study we evaluated the relationship between physical function, muscle mass, and age to provide an assessment of the disease and help prepare for therapeutic trials.

Methods: CDM participants performed timed functional tests (TFTs), the first 2 minutes of 6-minute walk tests (2/6MWTs), and myometry tests, and also performed dual-energy X-ray absorption (DEXA) scans. Healthy controls (HCs) performed TFTs, 6MWTs, and myometry.

Results: Thirty-seven children with CDM and 27 HCs (age range 3-13 years) participated in the study. There were significant differences in the 10-meter walk (11.3 seconds in CDM vs. 6.8 seconds in HC) and 2MWT (91 meters in CDM vs. 193 meters in HCs). DEXA lean mass of the right arm correlated with grip strength (r = 0.91), and lean mass of the right leg correlated with 6MWT (r = 0.62).

Conclusion: Children with CDM have significant limitations in strength and mobility. The tests performed were reliable, and lean muscle mass may serve as a useful biomarker. Muscle Nerve 56: 224-229, 2017.

Keywords: 6-minute walk test; congenital myotonic dystrophy; functional outcomes; myotonic dystrophy, mobility measures.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Comparison of TFTs for CDM and HC by age
Figure 2
Figure 2. Bland-Altman graphs of 2MWT and 6MWT test-retest reliability

References

    1. Mahadevan M, Tsilfidis C, Sabourin L, et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science. 1992;255:1253–5. - PubMed
    1. Fu YH, Pizzuti A, Fenwick RG, Jr, et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science. 1992;255:1256–8. - PubMed
    1. Brook JD, McCurrach ME, Harley HG, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell. 1992;69:385. - PubMed
    1. Canavese F, Sussman MD. Orthopaedic manifestations of congenital myotonic dystrophy during childhood and adolescence. J Pediatr Orthop. 2009;29:208–13. - PubMed
    1. Vanier TM. Dystrophia myotonica in childhood. Br Med J. 1960;2:1284–8. - PMC - PubMed

Publication types